An implantable or wearable lens for ophthalmic use, having a front surface and a rear surface, wherein at least one surface of said front surface and rear surface has an aspherical refractive profile with circular or rotational symmetry, or with cylindrical or non-rotational symmetry, with respect to the optical axis, and having a geometric elevation z(r) defined by a series expansion of Forbes polynomials, wherein said refractive profile generates an enhancement of the wavefront W(r) emerging from the lens such as to extend the depth of field thereof progressively and continuously in a power range between −1.0 D and 4.0 D.

An intraocular lens (IOL) folding device is described.

An ophthalmic multifocal lens, and a method of manufacturing same, at least comprising focal points for near, intermediate and far vision. The lens comprises a light transmissive lens body providing a refractive focal point, and a periodic light transmissive diffraction grating, extending concentrically over at least part of a surface of the lens body and providing a set of diffractive focal points. The diffraction grating is designed to operate as an optical wave splitter, the refractive focal point providing the focal point for intermediate vision and the diffractive focal points providing the focal points for near and far vision. The diffraction grating has an optical transfer function comprising a continuous periodic phase profile function having an argument modulated as a function of the radial distance (r) to the optical axis of the lens body, thereby tuning the light distribution in the focal points.

An ophthalmic implant including an intraocular lens (IOL) and at least one drug delivery device. The IOL including an anterior side, a posterior side, a lens, and at least one haptic extending outwardly from the lens and including a first haptic extending from the lens at a first optic-haptic junction. The at least one drug delivery device including a first drug delivery device including a pad and a fixation portion extending from the pad. The pad including at least one therapeutic agent contained therein, an anterior surface, a posterior surface, and a sidewall extending around the pad and between the anterior surface and the posterior surface. The drug delivery device configured for attachment to the IOL via the fixation portion. In an assembled state of the implant, the first drug delivery device is attached to the IOL and the pad overlays the first optic-haptic junction.

An ophthalmic implant including an intraocular lens (IOL) and at least one drug delivery device. The IOL including an anterior side, a posterior side, a lens, and at least one haptic extending outwardly from the lens and including a first haptic extending from the lens at a first optic-haptic junction. The at least one drug delivery device including a first drug delivery device including a pad and a fixation portion extending from the pad. The pad including at least one therapeutic agent contained therein, an anterior surface, a posterior surface, and a sidewall extending around the pad and between the anterior surface and the posterior surface. The drug delivery device configured for attachment to the IOL via the fixation portion. In an assembled state of the implant, the first drug delivery device is attached to the IOL and the pad overlays the first optic-haptic junction.

A prosthetic capsular device configured to be inserted in a natural capsular bag of an eye after removal of a lens includes a housing structure capable of containing an intraocular device. The housing structure includes a posterior side, an anterior side opposite the posterior side, lateral sides extending between the posterior side and the anterior side, and a cavity at least partially defined by the posterior side, the anterior side, and the lateral sides. The posterior side includes a refractive surface and an opening radially outward of the refractive surface. The anterior side includes an aperture capable of allowing at least one of insertion, removal, and replacement of an intraocular device. The cavity is capable of containing an intraocular device.

An intraocular implant device is operable in augmented reality and virtual reality configurations. The intraocular implant device includes an intraocular implant body shaped for positioning inside a lens chamber in an eye. The intraocular implant body has an anterior side facing the cornea of the eye and a posterior side facing the retina of the eye. A photoelectric sensor is disposed on the anterior side of the intraocular implant body. The photoelectric sensor is operable to receive natural, optimized or enhanced incident light through the cornea and to convert the received light into electrical energy for use with one or more circuit components disposed on the intraocular implant body.

A virtual aperture integrated into an intraocular lens is disclosed. Optical rays which intersect the virtual aperture are widely scattered across the retina causing the light to be virtually prevented from reaching detectable levels on the retina. The use of the virtual aperture helps remove monochromatic and chromatic aberrations yielding high-definition retinal images. For a given definition of acceptable vision, the depth of field is increased over a larger diameter optical zone. In addition, thinner intraocular lenses can be produced since the optical zone can have a smaller diameter. This in turn allows smaller corneal incisions and easier implantation surgery.

Apparatuses, systems and methods for providing improved ophthalmic lenses, particularly intraocular lenses (IOLs), include features for providing a range of vision. Chromatic aberrations may be reduced at near, distance, and intermediate vision.

An accommodative intraocular lens includes an optic body having an optical power changing structure. There are two supporting structures disposed opposite one another about the optic body, each supporting structure configured to be connected at a distal end to a ciliary body after implantation in an eye of a patient and connected at a proximal end to the optic body. The two supporting structures are a zeroing supporting structure and an actuating supporting structure. The zeroing supporting structure is configured to not change the optical power of the optic body in an installation mode and an operation mode of the accommodative intraocular lens. An actuating supporting structure is configured to not change the optical power of the optic body in the installation mode but is configured to change the optical power of the optic body in the operation mode of the accommodative intraocular lens.